Submitted by Anonymous (not verified) on 16 February 2024 - 15:00
Human medicines European public assessment report (EPAR): Mulpleo (previously Lusutrombopag Shionogi), lusutrombopag, Date of authorisation: 18/02/2019, Revision: 9, Status: Authorised
Source: